RemedyMeds describes a medicine-inclusive compounded plan. Mochi advertises an ongoing membership with medical and nutrition support, while medication and diagnostics are additional. That makes the billing model the first useful distinction.

Use the provider reviews for the current source details, then confirm a personal quote and clinical assessment. We compare public information rather than claiming to have received treatment from these services.

The billing distinction

Ask RemedyMeds for its current complete quote and supply interval. For Mochi, add the chosen medication to the ongoing membership and any diagnostics. Compare payment commitments and refund rules for the exact plan.

Provider details to compare

RemedyMeds: Confirm your current medication and renewal price. Our fresh homepage capture did not establish a single reliable current price for every plan. Request the exact price, renewal amount, medication, and shipment interval before enrolling. A quote should identify whether billing follows a calendar month or a 28-day cycle.

Mochi Health: Ongoing membership; medication costs extra. The homepage advertises a $39 new-member first month and an ongoing $79 monthly membership. Medication is additional and advertised medicine rates can be described as “as low as,” rather than the guaranteed price for every member or state.

Make the decision around your care needs

A nutrition appointment can be valuable when it meets your needs, but it should be counted as a service rather than treated as a free extra by default. Obtain the clinical assessment before deciding on the medicine.

Before paying, ask each clinical team who will prescribe, which pharmacy will dispense the medicine, and how follow-up works. Read cancellation and refund terms alongside the renewal price.

Continue your comparison

Compare the GLP-1 programs, read the CoreAge Rx review, and use the program table to prepare questions about the complete offer.

Provider details: RemedyMeds · Mochi Health

Sources & offer details

Public information retrieved on October 1, 2026. Provider statements describe the advertised offer; they do not independently establish treatment outcomes.

  1. RemedyMeds: Official information ↗
  2. Mochi Health: Official information ↗
  3. FDA: Unapproved GLP-1 drug concerns ↗